Supplementary Information Below is the link to the electronic supplementary material
Total GLP-1 was analyzed by a chemiluminescent enzyme-linked assay (Mercodia, Uppsala, Sweden, Catalog # 10-1278-01, RRID: AB_2892202) with, according to the manufacturer, a 100% specificity to the GLP-1 (936) amide
Structured follow-up included No commitment required 5 minutes Available to all Texas residents Real Results What to Expect: GLP-1 Weight Loss Results in Texas GLP-1 medications produce meaningful, sustained weight loss when combined with physician guidance
If you already have mood disorders, talk to your doctor before starting GLP-1 meds
While preclinical data on the peptide BPC-157 reveals profound therapeutic potential, clinicians are left navigating a landscape where robust human trials are conspicuously absent
At the same time, the decline in obesity rates has been modest so far, with the broader impact of GLP-1 drugs tempered by high costs, uneven access, and the time required for increased adoption to translate into population-level outcomes